from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0425c/ctpH

LFCtreatmentdescriptionclass of inhibitor

-1.113

Amikacinug/mL Amikacintranslation

-1.878

Cap5-10ug/mL Capreomycintranslation

-2.268

Rox10-50 ug/mL Roxithromycintranslation

-0.904

SM2-5 ug/mL Streptomycintranslation

-4.533

Tet5-10 ug/mL Tetracyclinetranslation

0.161

Rif0.2-5ug/mL Rifampicintranscription

0.686

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.176

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.681

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.133

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.008

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.221

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.447

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.895

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.122

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.467

Nigericin50 uM Nigericinrespiration

0.603

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.087

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.204

menadione6-10 ug/mL Menadionerespiration

1.212

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.486

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.363

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.479

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.446

NRP_1Non-replicating persistence stage 1dosRassociated

0.262

Amp0.2mg/mL AmpicillincellWall

0.112

Cephalexin20-100 ug/mL CephalexincellWall

0.010

Cerulenin0.32-5 ug/mL CerulenincellWall

0.017

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.106

EMB10-20 ug/mL EthambutolcellWall

-0.338

Eta12-40 ug/mL EthionamidecellWall

-0.645

INH0.2-0.4 ug/mL IsoniazidcellWall

0.078

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.608

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.395

BZA0.12 mg/mL BenzamidearomaticAmides

-0.140

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.019

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.705

H2O24 mM hydrogen peroxideDNAdamaging

-0.302

Levo10 ug/mL LevofloxacinDNAdamaging

-0.319

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.462

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.057

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.010

Antimycin12.5-50 ug/mL Antimycin A?

-0.316

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.868

PA_110-50 ug/mL Antitubercular compound PA-1?

0.977

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.616

PA8240.2-2 ug/mL PA-824?

0.240

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.578

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.557

Verapamil50 uM Verapamil?

0.233

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.033

methoxatin10-20 ug/mL Methoxatin?